Acuvue-now.com, April 14, 2009
It's earnings time again: Johnson & Johnson released Q1 2009 Earnings today. No surprises in this tough economy: Johnson & Johnson worldwide sales were down 7.2% compared to the 1st quarter in 2008 (Primarily because of the the impact of currency exchange rates). We extracted some comments from the earnings transcript that are specific to the vision care division. 

"...Rounding out the review of the medical devices and diagnostics segment our Vision Care franchise achieved operational sales growth of 0.6% in the first quarter compared to the same period last year. Sales in the US increased 3.5%. Sales outside the US declined 1.1% on an operational basis. The lens market overall is estimated to be flat compared to the same period last year. Despite the softness in the market Acuvue Oasys, 1-Day Acuvue Moist and the Acuvue Oasys for Astigmatism achieved strong double digit growth...."

Double-Digit Growth: We are impressed and think this is a good testimony that consumers really love these products.

Source: Acuvue-now.com; Johnson & Johnson Earnings Transcript (Q1 2009)